TWAS:,

Zerong Li1, Huayang Li2, Wenmei Qiao3

  • 1Department of Pharmacy, The Second People's Hospital of Shenzhen, The First Affiliated Hospital of Shenzhen University, Shenzhen, Guangdong, P. R. China.

概括

这项研究揭示了一个特定的内皮细胞状态驱动肺动脉高血压 (PAH) 的进展. 像KLF2,RASIP1和DEPP1这样的关键基因识别这些细胞,可能是PAH的治疗点.